Pineapple Financial has officially completed its $100 Million capital raise to purchase
$INJ.
Starting this month, Pineapple will accumulate
$INJ tokens and stake them with the aim of generating an estimated 12% annual yield, placing its strategy well ahead of major digital asset treasury approaches today.
Purchases will be publicly revealed and will be executed by institutional asset managers in the open market, with the accumulation program expected to continue over the coming weeks until the full $100 million worth of
$INJ is acquired. At current prices today, this represents about 7% of circulating supply. This already would make Pineapple one of the top ten holders of INJ with its goal of becoming the #1 INJ holder over time.
@PAPLpineapple, a fintech company listed on
@NYSE, is positioned to become the largest publicly traded holder of the Injective token globally. The raise attracted support from leading institutions in both traditional finance and crypto, including Kraken, FalconX, Canary Capital, the Injective Foundation, Monarq, and Abraxas.
The Injective treasury strategy is unlike any other to date both in terms of long term investor alignment and synergies with the core public company business. The Injective token is fully circulating with no scheduled unlocks for private investors, allowing Pineapple to accumulate through secondary markets without dilution or overhang risk.
Injective’s onchain revenues today far outpace many chains. This revenue is uniquely utilized directly to burn
$INJ with over 6.7 million already burned. Pineapple’s strategy to accumulate the Injective token while it is also being burned via revenues generated onchain creates a powerful flywheel for the Injective ecosystem long term.
In just the past year, Pineapple processed more than $2.5 billion in mortgages, volume it now intends to bring onto Injective. This dual alignment, acquiring the Injective token for treasury while onboarding its core TradFi business onchain with Injective, signals a powerful catalyst for bringing billions of dollars in tokenized assets and RWAs to the ecosystem.
Executives from the Injective Foundation will join Pineapple’s advisory board to guide its treasury approach, alongside global leaders who previously held senior roles at Galaxy Digital, Circle, UBS, Merrill Lynch, and Gemini. Their combined expertise will help shape Pineapple’s capital allocation strategy with the Injective token at its center.
The Pineapple treasury strategy is one that will put the Injective token first for years to come. Future capital raises are also expected to be dedicated to
$INJ accumulation, compounding both staking yield and circulating exposure over time. This again reinforces Pineapple’s commitment to Injective’s long term vision to bring all of finance onchain.
Traditional finance is built on capital access, and the Injective token represents a gateway for moving that system onto blockchain rails. By allocating $100 million exclusively to
$INJ, Pineapple underscores its conviction that Injective can power a more transparent and accessible financial future that works for all.